From the U.S. Government Accountability Office, www.gao.gov
Transcript for: Military Health Care 

Description: The Defense Health Agency (DHA) uses its clinical adverse
action process to investigate concerns about a health care provider's
quality of care, and if warranted, to take action to limit or prohibit
the care a provider is allowed to deliver. GAO reviewed 55 clinical
adverse action cases at four selected military medical treatment
facilities and found that they did not always adhere to certain
requirements. For example, in more than one-third of the cases, the
facilities did not adhere to the DHA requirement to establish a deadline
for the investigation of a provider. GAO also found that DHA did not
always report providers within required time frames. GAO is making six
recommendations, including for DHA to improve its monitoring approach
and establish timeliness requirements for steps in the clinical adverse
action process. 

Related GAO Works: GAO-24-106107. Military Health Care: DOD Should
Improve Its Process for Clinical Adverse Actions against Providers 

Released: April 2024
 
The Defense Health Agency investigates concerns about safety and the
quality  of care in DOD medical facilities. If DHA finds there is
evidence health care providers did not provide proper care, it can
prohibit or limit the services they can provide in DOD facilities. DHA
must also report the provider to a federal database that hospitals and
others can use to screen providers. 

But DHA didn't always report them within the required 30-day timeframe.
Also, it hasn't set timeliness standards for other steps in this
process, such as legal reviews and appeals meetings. We recommended
addressing timeliness issues, among other things, in this process.

 [ End ]

For more info, check out our report GAO-24-106107 at: GAO.gov